Law and Regulations

An ounce of prevention is well worth a pound of cure when it comes to DEA investigations.

Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN, discusses how med sync programs can help boost a pharmacy's bottom line.

Over the last two legislative sessions, many bills have been introduced in the both the House and the Senate, but there are four bills that are important to watch.

The new deadline to be in compliance with the requirements will be November 27, 2024.

A Q&A with Matt Sample, senior vice president of manufacturer and replenishment operations at AmerisourceBergen.

Illinois Governor JB Pritzker signed into a law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.

The Equitable Community Access to Pharmacy Services legislation was introduced earlier this year in the House of Representatives.

Filling a prescription for a controlled substance requires more oversight than the average prescription.

Despite the increase in drug costs outpacing inflation, Pennsylvania seniors are still paying the same amount for prescriptions that they did in 1990.

NCPA, NACDS, and APhA have joined the Healthcare Distribution Alliance in calling for a delay in the implementation of DSCSA.

The Drug Supply Chain Security Act has been a decade in the making. Pharmacists must be prepared to comply by November 2023.

Three new bills signed Monday will require PBMs to use prescription drug rebates to lower premiums and out-of-pocket costs for consumers and prevent the practice of spread pricing.

The revised guidance includes clarified aspects of the negotiation process and additional opportunities for engagement during the process.

A bipartisan group of 61 U.S. senators and 233 members of the U.S. House of Representatives signed onto a joint letter asking the Centers for Medicare & Medicaid Services to approve reforms.

Researchers of a new paper discuss the inconsistencies between gene and cell therapy indications and payor coverage.

The Protect Patient Access to Pharmacies Act will help to secure Medicare patients’ freedom to receive medications and care from the pharmacy of their choice.

According to a spokesperson, the company is prepared to take the lawsuit to the Supreme Court.

Members of the United States Senate Committee on Finance want to modernize the rules around PBM business practices to lower out-of-pocket costs and increase competition.

At the 2023 Asembia Specialty Pharmacy Summit, panelists discussed how inflation rebates and a redesign of Medicare Part D plans will impact payers and manufacturers.

Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.

The DEA is hoping to expand health care accessibility while also safeguarding from incorrectly prescribing medication.

United States leaders work together to create bipartisan solutions for the youth mental health crisis.